| UniProt ID | GLRX3_HUMAN | |
|---|---|---|
| UniProt AC | O76003 | |
| Protein Name | Glutaredoxin-3 | |
| Gene Name | GLRX3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 335 | |
| Subcellular Localization | Cytoplasm, cytosol . Cytoplasm, cell cortex . Cytoplasm, myofibril, sarcomere, Z line . Under the plasma membrane (By similarity). After PMA stimulation, GLRX3 and PRKCQ/PKC-theta translocate to a more extended submembrane area (By similarity). In th | |
| Protein Description | Together with BOLA2, acts as a cytosolic iron-sulfur (Fe-S) cluster assembly factor that facilitates [2Fe-2S] cluster insertion into a subset of cytosolic proteins. [PubMed: 26613676] | |
| Protein Sequence | MAAGAAEAAVAAVEEVGSAGQFEELLRLKAKSLLVVHFWAPWAPQCAQMNEVMAELAKELPQVSFVKLEAEGVPEVSEKYEISSVPTFLFFKNSQKIDRLDGAHAPELTKKVQRHASSGSFLPSANEHLKEDLNLRLKKLTHAAPCMLFMKGTPQEPRCGFSKQMVEILHKHNIQFSSFDIFSDEEVRQGLKAYSSWPTYPQLYVSGELIGGLDIIKELEASEELDTICPKAPKLEERLKVLTNKASVMLFMKGNKQEAKCGFSKQILEILNSTGVEYETFDILEDEEVRQGLKAYSNWPTYPQLYVKGELVGGLDIVKELKENGELLPILRGEN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAAGAAEAA ------CCCCHHHHH | 18.01 | 22223895 | |
| 18 | Phosphorylation | AAVEEVGSAGQFEEL HHHHHHCCCCCHHHH | 34.11 | 25693802 | |
| 32 | Phosphorylation | LLRLKAKSLLVVHFW HHHHHHCEEEEEEEE | 31.62 | - | |
| 67 | Ubiquitination | LPQVSFVKLEAEGVP CCCCEEEEEEECCCC | 38.30 | - | |
| 67 | Sumoylation | LPQVSFVKLEAEGVP CCCCEEEEEEECCCC | 38.30 | - | |
| 67 | Succinylation | LPQVSFVKLEAEGVP CCCCEEEEEEECCCC | 38.30 | 23954790 | |
| 79 | Ubiquitination | GVPEVSEKYEISSVP CCCCCCCCEEECCCC | 40.45 | - | |
| 92 | Acetylation | VPTFLFFKNSQKIDR CCEEEEECCCHHCCC | 48.64 | 25953088 | |
| 92 | Ubiquitination | VPTFLFFKNSQKIDR CCEEEEECCCHHCCC | 48.64 | 21906983 | |
| 96 | Ubiquitination | LFFKNSQKIDRLDGA EEECCCHHCCCCCCC | 46.53 | - | |
| 109 | Phosphorylation | GAHAPELTKKVQRHA CCCCHHHHHHHHHHH | 27.45 | 21406692 | |
| 110 | Acetylation | AHAPELTKKVQRHAS CCCHHHHHHHHHHHH | 64.67 | 23749302 | |
| 110 | 2-Hydroxyisobutyrylation | AHAPELTKKVQRHAS CCCHHHHHHHHHHHH | 64.67 | - | |
| 110 | Ubiquitination | AHAPELTKKVQRHAS CCCHHHHHHHHHHHH | 64.67 | - | |
| 111 | Ubiquitination | HAPELTKKVQRHASS CCHHHHHHHHHHHHC | 38.06 | - | |
| 117 | Phosphorylation | KKVQRHASSGSFLPS HHHHHHHHCCCCCCC | 29.16 | 29255136 | |
| 118 | Phosphorylation | KVQRHASSGSFLPSA HHHHHHHCCCCCCCH | 38.96 | 29255136 | |
| 120 | Phosphorylation | QRHASSGSFLPSANE HHHHHCCCCCCCHHH | 26.09 | 29255136 | |
| 124 | Phosphorylation | SSGSFLPSANEHLKE HCCCCCCCHHHHHHH | 45.96 | 28450419 | |
| 130 | Ubiquitination | PSANEHLKEDLNLRL CCHHHHHHHHHHHHH | 51.60 | - | |
| 139 | Ubiquitination | DLNLRLKKLTHAAPC HHHHHHHHHHHHCCE | 64.31 | - | |
| 146 | Glutathionylation | KLTHAAPCMLFMKGT HHHHHCCEEEEECCC | 2.95 | 22555962 | |
| 146 | S-nitrosylation | KLTHAAPCMLFMKGT HHHHHCCEEEEECCC | 2.95 | 24105792 | |
| 151 | Acetylation | APCMLFMKGTPQEPR CCEEEEECCCCCCCC | 52.91 | 25953088 | |
| 151 | Ubiquitination | APCMLFMKGTPQEPR CCEEEEECCCCCCCC | 52.91 | - | |
| 151 | Malonylation | APCMLFMKGTPQEPR CCEEEEECCCCCCCC | 52.91 | 26320211 | |
| 153 | Phosphorylation | CMLFMKGTPQEPRCG EEEEECCCCCCCCCC | 19.11 | 24300666 | |
| 163 | Acetylation | EPRCGFSKQMVEILH CCCCCCCHHHHHHHH | 39.90 | 25953088 | |
| 163 | Ubiquitination | EPRCGFSKQMVEILH CCCCCCCHHHHHHHH | 39.90 | - | |
| 165 | Sulfoxidation | RCGFSKQMVEILHKH CCCCCHHHHHHHHHC | 3.16 | 30846556 | |
| 177 | Phosphorylation | HKHNIQFSSFDIFSD HHCCCCCCEEECCCH | 17.45 | 30624053 | |
| 178 | Phosphorylation | KHNIQFSSFDIFSDE HCCCCCCEEECCCHH | 28.38 | 30624053 | |
| 183 | Phosphorylation | FSSFDIFSDEEVRQG CCEEECCCHHHHHHH | 44.43 | - | |
| 196 | Phosphorylation | QGLKAYSSWPTYPQL HHHHHHHCCCCCCEE | 25.13 | - | |
| 200 | Phosphorylation | AYSSWPTYPQLYVSG HHHCCCCCCEEEEEC | 5.72 | - | |
| 229 | Glutathionylation | SEELDTICPKAPKLE HHCHHHHCCCCCCHH | 2.84 | 22555962 | |
| 231 | Ubiquitination | ELDTICPKAPKLEER CHHHHCCCCCCHHHH | 73.28 | - | |
| 234 | Acetylation | TICPKAPKLEERLKV HHCCCCCCHHHHHHH | 73.68 | 25953088 | |
| 234 | Ubiquitination | TICPKAPKLEERLKV HHCCCCCCHHHHHHH | 73.68 | - | |
| 240 | Ubiquitination | PKLEERLKVLTNKAS CCHHHHHHHHHCCCC | 41.23 | 21890473 | |
| 247 | Phosphorylation | KVLTNKASVMLFMKG HHHHCCCCEEEEECC | 15.07 | 30622161 | |
| 253 | Acetylation | ASVMLFMKGNKQEAK CCEEEEECCCCHHHC | 52.58 | 25953088 | |
| 260 | Acetylation | KGNKQEAKCGFSKQI CCCCHHHCCCCHHHH | 33.85 | 25953088 | |
| 296 | Phosphorylation | VRQGLKAYSNWPTYP HHHHHHHHHCCCCCC | 10.84 | 21406692 | |
| 297 | Phosphorylation | RQGLKAYSNWPTYPQ HHHHHHHHCCCCCCE | 36.96 | 21406692 | |
| 301 | Phosphorylation | KAYSNWPTYPQLYVK HHHHCCCCCCEEEEC | 39.17 | 21406692 | |
| 302 | Phosphorylation | AYSNWPTYPQLYVKG HHHCCCCCCEEEECC | 5.72 | 21406692 | |
| 306 | Phosphorylation | WPTYPQLYVKGELVG CCCCCEEEECCEEEC | 8.55 | 21406692 | |
| 319 | Ubiquitination | VGGLDIVKELKENGE ECCHHHHHHHHHCCC | 58.63 | - | |
| 322 | Ubiquitination | LDIVKELKENGELLP HHHHHHHHHCCCEEC | 50.67 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GLRX3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GLRX3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GLRX3_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...